Lineage Cell Therapeutics Inc
TASE:LCTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lineage Cell Therapeutics Inc
TASE:LCTX
|
US |
|
Celanese Corp
NYSE:CE
|
US |
|
10X Genomics Inc
NASDAQ:TXG
|
US |
|
Colony Bankcorp Inc
NASDAQ:CBAN
|
US |
|
General Dynamics Corp
NYSE:GD
|
US |
|
P
|
Pensionbee Group PLC
LSE:PBEE
|
UK |
|
Crown Holdings Inc
NYSE:CCK
|
US |
|
Magna International Inc
TSX:MG
|
CA |
|
P
|
PennantPark Floating Rate Capital Ltd
NYSE:PFLT
|
US |
|
Bank Mandiri (Persero) Tbk PT
IDX:BMRI
|
ID |
|
Olaplex Holdings Inc
NASDAQ:OLPX
|
US |
|
Abbott Laboratories
NYSE:ABT
|
US |
|
UOB-Kay Hian Holdings Ltd
SGX:U10
|
SG |
|
Stewart Information Services Corp
NYSE:STC
|
US |
|
I
|
Impianti SpA
MIL:MPT
|
IT |
|
M
|
Mit SIM SpA
MIL:MTS
|
IT |
|
Vale SA
BOVESPA:VALE3
|
BR |
|
I
|
IN8BIO, Inc.
NASDAQ:INAB
|
US |
|
Italian Exhibition Group SpA
MIL:IEG
|
IT |
|
Nomad Foods Ltd
NYSE:NOMD
|
UK |
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
US |
|
Afya Ltd
NASDAQ:AFYA
|
BR |
|
Fairfax Financial Holdings Ltd
TSX:FFH
|
CA |
|
Armstrong World Industries Inc
NYSE:AWI
|
US |
Wall St Price Targets
LCTX Price Targets Summary
Lineage Cell Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for LCTX is 1 637.87 ILS with a low forecast of 884.62 ILS and a high forecast of 2 758.97 ILS.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LCTX's stock price target?
Price Target
1 637.87
ILS
According to Wall Street analysts, the average 1-year price target for LCTX is 1 637.87 ILS with a low forecast of 884.62 ILS and a high forecast of 2 758.97 ILS.
What is the Revenue forecast for Lineage Cell Therapeutics Inc?
Projected CAGR
58%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 58%.
